Clinical Trial of TQB3002 in Patients With Advanced Cancers

NCT06662760 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: TQB3002 Tablets

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.